These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8014586)

  • 1. Ultracentrifugal subclasses of low and intermediate density lipoproteins.
    Opplt JJ; Holzberg ES
    J Lipid Res; 1994 Mar; 35(3):510-23. PubMed ID: 8014586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneous properties of intermediate- and low-density lipoprotein subpopulations.
    Srisawasdi P; Vanavanan S; Rochanawutanon M; Pornsuriyasak P; Tantrakul V; Kruthkul K; Kotani K
    Clin Biochem; 2013 Oct; 46(15):1509-15. PubMed ID: 23830843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of early diabetic nephropathy on very low density lipoprotein (VLDL), intermediate density lipoprotein (IDL), and low density lipoprotein (LDL) composition.
    Winocour PH; Durrington PN; Bhatnagar D; Ishola M; Mackness M; Arrol S
    Atherosclerosis; 1991 Jul; 89(1):49-57. PubMed ID: 1772471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of hepatic and lipoprotein lipase activities with changes in dietary composition and low density lipoprotein subclasses.
    Campos H; Dreon DM; Krauss RM
    J Lipid Res; 1995 Mar; 36(3):462-72. PubMed ID: 7775858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective, observation study: Quantitative and qualitative effect of ezetimibe and HMG-CoA reductase inhibitors on LDL-cholesterol: are there disappearance thresholds for small, dense LDL and IDL?
    Inoue I; Awata T; Katayama S
    Recent Pat Cardiovasc Drug Discov; 2010 Jun; 5(2):143-52. PubMed ID: 20423317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of apoB-100 in lipoproteins separated by density gradient ultracentrifugation in normal and Watanabe heritable hyperlipidemic rabbits.
    Shames DM; Yamada N; Havel RJ
    J Lipid Res; 1990 May; 31(5):753-62. PubMed ID: 2380627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of combination nicotinic acid and gemfibrozil treatment on intermediate density lipoprotein, and subclasses of low density lipoprotein and high density lipoprotein in patients with combined hyperlipidemia.
    Superko HR; Garrett BC; King SB; Momary KM; Chronos NA; Wood PD
    Am J Cardiol; 2009 Feb; 103(3):387-92. PubMed ID: 19166694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of lipoprotein subclasses by proton nuclear magnetic resonance-based partial least-squares regression models.
    Petersen M; Dyrby M; Toubro S; Engelsen SB; Nørgaard L; Pedersen HT; Dyerberg J
    Clin Chem; 2005 Aug; 51(8):1457-61. PubMed ID: 15961551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization with zonal ultracentrifugation of low-density lipoproteins in type V hyperlipoproteinemia.
    Manzato E; Gasparotto A; Marin R; Baggio G; Baldo G; Crepaldi G
    Biochim Biophys Acta; 1984 May; 793(3):365-71. PubMed ID: 6712974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of very-low-density, intermediate-density, and low-density lipoproteins with human arterial wall proteoglycans.
    Anber V; Millar JS; McConnell M; Shepherd J; Packard CJ
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2507-14. PubMed ID: 9409221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small-dense LDL/large-buoyant LDL ratio associates with the metabolic syndrome.
    Srisawasdi P; Vanavanan S; Rochanawutanon M; Kruthkul K; Kotani K; Kroll MH
    Clin Biochem; 2015 May; 48(7-8):495-502. PubMed ID: 25645359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlative design of electrophoretic and ultracentrifugal investigation of metabolic effects of probucol.
    Opplt JJ; Chick LL; Opplt MA
    Artery; 1982; 10(2):131-49. PubMed ID: 7092580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A short-run new analytical ultracentrifugal micromethod for determining low-density lipoprotein sub-fractions using Schlieren refractometry.
    Bozóky Z; Fülöp L; Köhidai L
    Eur Biophys J; 2001; 29(8):621-7. PubMed ID: 11288837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperapobetalipoproteinemia with compositional abnormality of LDL and IDL, a characteristic lipoprotein alteration in essential hypertension.
    Ryomoto KI; Suzuki M; Kanazawa A; Hasegawa M; Kimura Y; Yamamura T; Harano Y
    Am J Hypertens; 2000 Jun; 13(6 Pt 1):617-24. PubMed ID: 10912744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of HDL and lipoproteins intermediate to LDL and HDL in the serum of pedigreed baboons fed an atherogenic diet.
    Babiak J; Gong EL; Nichols AV; Forte TM; Kuehl TJ; McGill HC
    Atherosclerosis; 1984 Jul; 52(1):27-45. PubMed ID: 6466414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decrease of plasma large, light LDL (LDL1), HDL2 and HDL3 levels with concomitant increase of cholesteryl ester transfer protein (CETP) activity by probucol in type II hyperlipoproteinemia.
    Homma Y; Kobayashi T; Yamaguchi H; Sakane H; Ozawa H; Matsuda M; Mikami Y; Mikami Y; Nakamura H
    Artery; 1993; 20(1):1-18. PubMed ID: 8447724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of low molecular weight heparin compared to conventional heparin for anticoagulation during haemodialysis on low density lipoprotein subclasses.
    Wiemer J; Winkler K; Baumstark M; März W; Scherberich JE
    Nephrol Dial Transplant; 2002 Dec; 17(12):2231-8. PubMed ID: 12454238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholesterol profile measurement by vertical auto profile method.
    Kulkarni KR
    Clin Lab Med; 2006 Dec; 26(4):787-802. PubMed ID: 17110240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of multiple subclasses of plasma low density lipoproteins in normal humans.
    Krauss RM; Burke DJ
    J Lipid Res; 1982 Jan; 23(1):97-104. PubMed ID: 7057116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
    Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ
    Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.